Frontlight ResearchEarly access
Myeloproliferative neoplasms trials in United States
118 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Early phase 1Taking peopleMomelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Chronic Neutrophilic Leukemia
- Where
- Baltimore
- Age
- 18 years to 100 years
- People
- 18
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT07071155 - Phase 3Taking peopleStudy on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
- Where
- Bethesda, Birmingham, Chapel Hill, Cleveland, Englewood, Eugene, Houston, New York, Redlands, Roanoke, Salt Lake City, Seattle, Sherman
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- Italfarmaco
See details and how to joinNCT06093672 · EU 2022-502276-23-00 - Phase 2Taking peopleA Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- Where
- Birmingham, Boston, Chapel Hill, Charlottesville, Detroit, Duarte, Houston, Miami, New York, Palo Alto, Portland, Seattle, Westwood
- Age
- 18 years to 66 years
- People
- 358
- Run by
- Center for International Blood and Marrow Transplant Research
See details and how to joinNCT06859424 - Phase 2Taking peopleCord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
- Where
- New York
- Age
- Up to 21 years
- People
- 31
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT04644016 - Phase 1/2Taking peopleAn Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms
- Where
- Irvine, Orange
- Age
- 18 years and over
- People
- 27
- Run by
- University of California, Irvine
See details and how to joinNCT05123365 - Phase 2Taking peopleA Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
- Where
- Cleveland, Columbia, Duarte, Durham, Houston, New York, Salt Lake City
- Age
- 18 years and over
- People
- 58 worldwide
- Run by
- Karyopharm Therapeutics Inc
See details and how to joinNCT05980806 - No phaseTaking peopleMPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
- Where
- Chicago, New York
- Age
- 18 years and over
- People
- 5,000
- Run by
- MPN Research Foundation
See details and how to joinNCT07362225 - Phase 2Taking peopleRuxolitinib in Thrombocythemia and Polycythemia Vera
- Where
- Boston, Danvers
- Age
- 18 years and over
- People
- 60
- Run by
- Massachusetts General Hospital
See details and how to joinNCT04644211 - Phase 1Taking peopleSelumetinib and Azacitidine in High Risk Chronic Blood Cancers
- Where
- Chicago
- Age
- 18 years and over
- People
- 18
- Run by
- University of Chicago
See details and how to joinNCT03326310 - Phase 2Taking peopleMethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial
- Where
- New York
- Age
- 18 years and over
- People
- 54
- Run by
- Icahn School of Medicine at Mount Sinai
See details and how to joinNCT06541249 - Phase 2Taking peopleTwo Step Haplo With Radiation Conditioning
- Where
- Philadephia
- Age
- 18 years and over
- People
- 63
- Run by
- Thomas Jefferson University
See details and how to joinNCT05031897 - No phaseTaking peopleSYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Where
- Albuquerque, Ann Arbor, Atlanta, Aurora, Baltimore, Bethesda, Billings, Birmingham, Boise, Buffalo, Chapel Hill, Charlottesville, Chicago, Cincinnati, Columbus, Dallas, Denver, Duarte, Duluth, Fargo, Greenville, Hartford, Hattiesburg, Hempstead, Houston, Iowa City, Irvine, Jacksonville, Kansas City, La Jolla, Lansing, Little Rock, Littleton, Manhasset, Mayfield Heights, Memphis, Miami, Milwaukee, Mobile, Morgantown, Nashville, Newark, New Brunswick, New Orleans, New York, Norwalk, Omaha, Orange, Philadelphia, Portland, Providence, Salt Lake City, San Francisco, Savannah, Scarborough, Scottsdale, Seattle, Silver Spring, Stanford, Staten Island, St Louis, Tampa, Temple, Towson, Tulsa, Winston-Salem, Worcester
- People
- 50,000 worldwide
- Run by
- Massive Bio, Inc.
See details and how to joinNCT03452774 - Phase 1Taking peopleQ702 for the Treatment of Patients With Hematologic Malignancies
- Where
- Rochester, Scottsdale
- Age
- 18 years and over
- People
- 46
- Run by
- Mayo Clinic
See details and how to joinNCT06712810 - No phaseTaking peopleI Can Move With Purpose Now! A Pilot Lifestyle Intervention Study in Myeloproliferative Neoplasm Patients
- Where
- Boston
- Age
- 18 years and over
- People
- 30
- Run by
- Massachusetts General Hospital
See details and how to joinNCT05842603 - Phase 3Taking peopleStudy of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
- Where
- Ann Arbor, Aurora, Baltimore, Baton Rouge, Bethesda, Birmingham, Boston, Brooklyn, Canton, Charleston, Charlotte, Chattanooga, Cincinnati, Cleveland, Dallas, Des Moines, Detroit, Durham, Eugene, Gilbert, Hackensack, Henderson, Houston, Independence, Ithaca, Jacksonville, La Jolla, Lake Success, Lincoln, Los Angeles, Louisville, Mayfield Heights, Miami, Nashville, Newark, New York, Orlando, Philadelphia, Phoenix, Pittsburgh, Richmond, Salt Lake City, San Antonio, San Diego, Seattle, Sheboygan, Tacoma, Tampa, The Bronx, Torrance, Virginia Beach, Washington D.C., Westwood, Wilson, Winston-Salem
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- Kartos Therapeutics, Inc.
See details and how to joinNCT06479135 - Phase 1Taking peoplePacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 24
- Run by
- Fox Chase Cancer Center
See details and how to joinNCT06218628 - No phaseTaking peopleProspective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
- Where
- Minneapolis
- Age
- 55 years and over
- People
- 650
- Run by
- Center for International Blood and Marrow Transplant Research
See details and how to joinNCT02934477 - Phase 1/2Taking peopleStudy of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib
- Where
- Birmingham, Canton, Cincinnati, Houston
- Age
- 18 years and over
- People
- 70 worldwide
- Run by
- Telios Pharma, Inc.
See details and how to joinNCT05280509